Yayın:
Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome

dc.contributor.authorAktaş, Nimet
dc.contributor.buuauthorOruç, Ayşegül
dc.contributor.buuauthorAyar, Yavuz
dc.contributor.buuauthorVuruşkan, Berna Aytaç
dc.contributor.buuauthorYıldız, Abdülmecit
dc.contributor.buuauthorYavuz, Mahmut
dc.contributor.buuauthorGüllülü, Mustafa
dc.contributor.buuauthorDilek, Kamil
dc.contributor.buuauthorErsoy, Alparslan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPatoloji Ana Bilim Dalı
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.departmentNefroloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-0342-9692
dc.contributor.orcid0000-0003-4607-9220
dc.contributor.researcheridAAH-4002-2021
dc.contributor.researcheridO-9948-2015
dc.contributor.researcheridAAH-9746-2021
dc.contributor.researcheridAGF-0767-2022
dc.contributor.researcheridGSE-0029-2022
dc.contributor.scopusid55133912100
dc.contributor.scopusid55860143300
dc.contributor.scopusid56527372000
dc.contributor.scopusid56256977500
dc.contributor.scopusid7006244754
dc.contributor.scopusid6602684544
dc.contributor.scopusid56005080200
dc.contributor.scopusid35612977100
dc.date.accessioned2023-11-09T06:21:49Z
dc.date.available2023-11-09T06:21:49Z
dc.date.issued2018
dc.identifier.citationOruç, A. vd. (2018). ''Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome''. Nefrologia, 38(4), 448-450.
dc.identifier.doi10.1016/j.nefroe.2018.04.004
dc.identifier.endpage450
dc.identifier.issn0211-6995
dc.identifier.issn1989-2284
dc.identifier.issue4
dc.identifier.pubmed29221881
dc.identifier.scopus2-s2.0-85049994526
dc.identifier.startpage448
dc.identifier.urihttps://doi.org/10.1016/j.nefroe.2018.04.004
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S2013251418300622
dc.identifier.urihttp://hdl.handle.net/11452/34810
dc.identifier.volume38
dc.identifier.wos000439099700019
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherSoc Espanola Nefrologia Dr Rafael Matesanz
dc.relation.collaborationSanayi
dc.relation.journalNefrologia
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectUrology & nephrology
dc.subjectComplement inhibitor eculizumab
dc.subject.emtreeAminotransferase
dc.subject.emtreeAmlodipine
dc.subject.emtreeCarvedilol
dc.subject.emtreeCreatinine
dc.subject.emtreeEculizumab
dc.subject.emtreeLactate dehydrogenase
dc.subject.emtreeMethyldopa
dc.subject.emtreeRamipril
dc.subject.emtreeEculizumab
dc.subject.emtreeMonoclonal antibody
dc.subject.emtreeAdult
dc.subject.emtreeBlood pressure regulation
dc.subject.emtreeBlood smear
dc.subject.emtreeCase report
dc.subject.emtreeClinical article
dc.subject.emtreeCreatinine blood level
dc.subject.emtreeDisease classification
dc.subject.emtreeDrug withdrawal
dc.subject.emtreeEchography
dc.subject.emtreeFatty liver
dc.subject.emtreeHeadache
dc.subject.emtreeHemolytic uremic syndrome
dc.subject.emtreeHepatomegaly
dc.subject.emtreeHuman
dc.subject.emtreeHuman cell
dc.subject.emtreeHuman tissue
dc.subject.emtreeHypertension retinopathy
dc.subject.emtreeKidney biopsy
dc.subject.emtreeLaboratory test
dc.subject.emtreeLactate dehydrogenase blood level
dc.subject.emtreeLetter
dc.subject.emtreeLiver toxicity
dc.subject.emtreeMale
dc.subject.emtreePhysical examination
dc.subject.emtreePlasma exchange
dc.subject.emtreeThrombocytopenia
dc.subject.emtreeThrombotic thrombocytopenic purpura
dc.subject.emtreeTreatment duration
dc.subject.emtreeComplication
dc.subject.emtreeHemolytic uremic syndrome
dc.subject.emtreeToxic hepatitis
dc.subject.meshAdult
dc.subject.meshAntibodies, monoclonal, humanized
dc.subject.meshAtypical hemolytic uremic syndrome
dc.subject.meshChemical and drug induced liver injury
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.wosUrology & nephrology
dc.titleHepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome
dc.title.alternativeHepatotoxicidad asociada con eculizumab en un paciente con síndrome urémico hemolítico atípico
dc.typeLetter
dc.wos.quartileQ4
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı/Nefroloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Patoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Küçük Resim
Ad:
Oruç_vd_2018.pdf
Boyut:
540.59 KB
Format:
Adobe Portable Document Format
Açıklama

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama